首页 > 抗体蛋白 > 抗体
PE/Cyanine7 anti-mouse CD25 Antibody
产品名称:
PE/Cyanine7 anti-mouse CD25 Antibody
产品类别:
抗体
产品编号:
102015
产品应用:
102015
[价格]
规格 价格 库存
25µg ¥ 1218 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
IL-2-dependent cytolytic mouse T-cell clone B6.1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation1,2, in vitro blocking of IL-2 binding to low- and high-affinity receptors1-4, growth inhibition of IL-2-dependent T-cell lines1-4, in vivo depletion of CD25+CD4+ Treg cells5-8,10, and immunohistochemical staining of acetone-fixed frozen sections2. PC61 antibody recognizes a different epitope than 3C7 antibody (Cat. No. 101902).?For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF? purified antibody (Cat. No. 102040) with endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered.?

Additional Product Notes
BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Lowenthal JW, et al. 1985. Nature 315:669. (IP, Block)
  2. Ceredig R, et al. 1985. Nature 314:98. (IP, IHC, Block)
  3. Lowenthal JW, et al. 1985. J. Immunol. 135:3988. (Block)
  4. Moreau JL, et al. 1987. Eur. J. Immunol. 17:929. (Block)
  5. Takahashi T, et al. 2000. J. Exp. Med. 192:303. (Deplete)
  6. Onizuka S, et al. 1999. Cancer Res. 59:3128. (Deplete)
  7. Lei TC, et al. 2005. Blood 105:4865. (Deplete)
  8. Pasare C, et al. 2004. Immunity 21:733. (Deplete)
  9. León-Ponte M, et al. 2007. Blood 109:3139.
  10. Cao OW, et al. 2007. Blood doi:10.1182/blood-2007-02-073304. (Deplete)
  11. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719.
  12. Liu F, et al. 2011. Arch Toxicol. 85:1383. PubMed
  13. Anguela XM, et al. 2013. Diabetes. 62:551. PubMed
Product Citations
  1. Gruber R, et al. 2014. J Neurosci. 34:16320. PubMed
  2. Kawabe T, et al. 2020. Nat Commun. 2.795833333. PubMed
  3. Wilden A, et al. 2022. Front Immunol. 13:991295. PubMed
  4. Fu Z, et al. 2019. Cell Rep. 28:159. PubMed
  5. Wilfahrt D, et al. 2021. Elife. 10:. PubMed
  6. Prasad M, et al. 2020. Cell Mol Immunol. . PubMed
  7. Andrade MS, et al. 2022. JCI Insight. 7:. PubMed
  8. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  9. Elisabeth Schrumpf, Xiaojun Jiang 2017. Physiol Rep. 10.14814/phy2.13117. PubMed
  10. Hiraishi Y, et al. 2018. Sci Rep. 8:18052. PubMed
  11. Isoda T et al. 2017. Cell. 171(1):103-119 . PubMed
  12. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  13. Achmus L, et al. 2020. Front Neurol. 11:577971. PubMed
  14. Liu Q, et al. 2021. Cell Death Dis. 12:240. PubMed
  15. Petursdottir D, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01699. PubMed
  16. Aqel SI, et al. 2021. JCI Insight. 6:e142376. PubMed
  17. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  18. Yang W, et al. 2020. Mucosal Immunol. 13:788. PubMed
  19. Paprckova D, et al. 2022. Front Immunol. 13:1009198. PubMed
  20. Martinikova AS, et al. 2020. Cells. 9:00. PubMed
  21. Suah AN, et al. 2021. J Clin Invest. 131:. PubMed
  22. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  23. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  24. Shan M et al. 2018. Immunity. 49(4):709-724 . PubMed
  25. Xiong Y, et al. 2018. Int J Clin Exp Pathol. 3.803472222. PubMed
  26. Benechet AP, et al. 2019. Nature. 574:200. PubMed
  27. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  28. Trompette A, et al. 2022. Mucosal Immunol. :. PubMed
  29. Ng SS, et al. 2020. Nat Immunol. 21:1205. PubMed
  30. Knizkova D, et al. 2022. Nat Immunol. 23:1644. PubMed
  31. Sido J, et al. 2015. J Leukoc Biol. 98: 435-447. PubMed
  32. Ku C, et al. 2015. Genes Dev. 29: 1930-1941. PubMed
  33. De Simone G, et al. 2021. Immunity. :. PubMed
  34. Horkova V, et al. 2020. Cell Reports. 30(5):1504-1514.e7.. PubMed
  35. Sinclair LV, et al. 2020. Immunometabolism. 2:e200029. PubMed
  36. Lindner J, et al. 2014. J Immunol. 192:4483. PubMed
  37. Coronel MM, et al. 2020. Sci Adv. 6:eaba5573. PubMed
  38. Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed
  39. Biton M et al. 2018. Cell. 175(5):1307-1320 . PubMed
  40. Moore MJ et al. 2018. eLife. 7 pii: e33057. PubMed
  41. De Ponte Conti B, et al. 2021. Elife. 10:. PubMed
  42. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  43. Evgin L, et al. 2020. Nat Commun. 2.671527778. PubMed
  44. Perry JL, et al. 2020. ACS Nano. 5.583333333. PubMed
  45. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  46. Zhai X, et al. 2021. Sci Adv. 7:eabk0490. PubMed
  47. Dionisio-Santos DA, et al. 2021. Front Neurosci. 15:758677. PubMed
  48. Moreau H, et al. 2015. Proc Natl Acad Sci U S A. 112: 12151-12156. PubMed
  49. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  50. Qadir AS, et al. 2021. iScience. 24:103348. PubMed
  51. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  52. Fernández-Orth J, et al. 2020. Eur J Immunol. . PubMed
  53. Li D, et al. 2020. Immunohorizons. 0.661805556. PubMed
  54. Mairhofer D, et al. 2015. J Invest Dermatol. 135: 2785-93. PubMed
  55. Rao R, et al. 2015. Toxicol Sci. 144:284. PubMed
  56. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  57. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  58. Li J, et al. 2021. Cell Rep. 37:110124. PubMed
  59. Fleskens V, et al. 2019. Cell Rep. 26:3600. PubMed
  60. Teng F, et al. 2021. Cell Rep. 37:110051. PubMed
  61. Zaiss M, et al. 2015. Immunity. 43: 998-1010. PubMed
  62. Kashiwakura Y, et al. 2020. Clinical & Experimental Immunology. 202(1):119-135. PubMed
  63. Steinmann S, et al. 2020. Sci Rep. 1.160416667. PubMed
  64. Kastenschmidt JM, et al. 2021. Cell Rep. 35:108997. PubMed
  65. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  66. Liu A, et al. 2022. Front Cell Infect Microbiol. 12:960208. PubMed
  67. Nabekura T, et al. 2020. Immunity. 96:52. PubMed
RRID
AB_312864 (BioLegend Cat. No. 102015) AB_312865 (BioLegend Cat. No. 102016)

Antigen Details

Structure
Forms high affinity IL-2R with IL-2Rβ (CD122) and IL-2Rγ (CD132), 55 kD
Distribution

Activated T cells and B cells, thymocyte subset, pre-B cells, T regulatory cells

Function
IL-2 receptor
Ligand/Receptor
IL-2
Cell Type
B cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules, Cytokine/Chemokine Receptors
Antigen References
  1. Taniguchi T, et al. 1993. Cell 73:5-8.
  2. Waldmann TA. 1991. J?Biol?Chem. 266:2681-4.
  3. Read S, et al. 2000. J Exp?Med. 192:295-302.
  4. Lowenthal JW, et al. 1985. J?Immunol. 135:3988-94.
Gene ID
16184 View all products for this Gene ID
UniProt
View information about CD25 on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线